As Department of Health and Human Services (HHS) and FDA leadership continue to look for ways to boost transparency and ...

The FDA said it has begun publishing reports of adverse events concerning drugs on a daily basis, instead of quarterly, as it ...

The FDA Adverse Event Reporting System, which Commissioner Marty Makary called “clunky,” previously published updates on a ...

The U.S. Food and Drug Administration said that it has begun the daily publication of adverse event reports related to drugs ...

(For example, 28% of women who were hospitalized experienced one or more adverse drug reactions compared to 21% of men, according to a July 2024 report in the Journal of the American Geriatrics ...

The FDA will now publish adverse event data from FAERS on a daily basis, marking a major step toward greater transparency in drug development.

The clinical observation of an adverse drug event often provides the initial alert associated with potential undesired drug effects. Similarly, case reports of adverse drug interactions have ...

The U.S. Food and Drug Administration has started "real-time reporting of adverse event data," according to an annoucement ...

The research, published Feb. 6 in Production and Operations Management, examined a large sample of mature generic drugs and found that those produced in India had a 54% higher rate of serious ...

A new study reveals that generic drugs manufactured in India have a higher association with severe adverse events such as hospitalization, disability, and death compared to those made in the U.S ...